Achaogen COO Promoted to Top Post, Effective Jan. 1, 2018 Post author:Sam Post published:December 11, 2017 Post category:BioPharma Dr. Hillan will remain on, and Mr. Wise will join, the Company’s Board of Directors. Source: BioSpace You Might Also Like Innate Tanked as Drug Combined With Bristol-Myers' Opdivo Flopped in Study November 26, 2017 Safety Concerns Raised as Ionis Pharma's Inotersen Meets Both Primary Endpoints in Late-Stage Study May 14, 2017 <b>Mike Hooven</b>, Founder Of AtriCure And Enable Injections, Joins Genetesis Board Of Directors October 10, 2017
Safety Concerns Raised as Ionis Pharma's Inotersen Meets Both Primary Endpoints in Late-Stage Study May 14, 2017
<b>Mike Hooven</b>, Founder Of AtriCure And Enable Injections, Joins Genetesis Board Of Directors October 10, 2017
